{"id":"NCT02975999","sponsor":"Wake Forest University Health Sciences","briefTitle":"Use of Vasopressin Following the Fontan Operation","officialTitle":"Use of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter Studies","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-12","primaryCompletion":"2019-12","completion":"2019-12","firstPosted":"2016-11-29","resultsPosted":"2024-10-09","lastUpdate":"2024-10-24"},"enrollment":12,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pleural Effusion","Single-ventricle"],"interventions":[{"type":"DRUG","name":"Vasopressin","otherNames":["Vasostrict, arginine"]},{"type":"DRUG","name":"Normal Saline","otherNames":["Placebo"]}],"arms":[{"label":"Vasopressin","type":"EXPERIMENTAL"},{"label":"Normal saline","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this pilot study is to prepare for a larger study to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.","primaryOutcome":{"measure":"Chest Tube Drainage","timeFrame":"From post operative day 0 through study completion, an average of 1 month","effectByArm":[{"arm":"Vasopressin","deltaMin":686.83,"sd":307.03},{"arm":"Normal Saline","deltaMin":535.5,"sd":140.29}],"pValues":[]},"eligibility":{"minAge":"18 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":6},"commonTop":[]}}